ArticleInternational journal of cardiology2025
Left ventricular hypertrophy and ventricular ectopy in mitral valve prolapse.
Article in International journal of cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Arrhythmogenic Spectrum of Mitral Valve Disease: Pathophysiology, Risk Stratification, and Surgical Management.Journal of clinical medicine · 2026Review
- Quadratic stratification of left ventricular hypertrophy and association with mitral insufficiency grading: a retrospective study using cardiac magnetic resonance.Cardiovascular diagnosis and therapy · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundSudden deaths ascribed to mitral valve prolapse (MVP) have increased ventricular mass on autopsy. It is unknown if left ventricular hypertrophy (LVH) is a risk factor for ventricular arrhythmia in MVP.
methodsWe studied all 629 patients aged 18-90 years with MVP on echocardiography between 2016 and 19 at our institution. Echocardiograms were reviewed for LVH, ventricular size and function, and valvular pathology. Complex or frequent ventricular ectopy (cfVE) was defined as ≥ 2 premature ventricular complexes (PVC) on a 10-s ECG or > 1 % PVC burden or non-sustained ventricular tachycardia on ambulatory ECG. Multivariable logistic regression and cox proportional hazards regression were used to assess the relationships between LVH, mitral valve structural features, and cfVE in MVP.
resultsLVH was present in 141 (22.4 %) patients. Of those with LVH, 44 (31.2 %) had cfVE compared to 87 (17.8 %) without LVH (p = 0.001). Independent predictors of cfVE were mitral annular disjunction (OR [95 % CI] 2.34 [1.54-3.56]), bileaflet prolapse (1.78 [1.19-2.66]), heart failure (1.79 [1.15-2.79]), lower ejection fraction (0.18 [0.04-0.83]), coronary artery disease (1.58 [1.04-2.39]), and T-wave inversion (1.51 [1.03-2.22]). However, LVH was not independently associated with cfVE (1.22 [0.82-1.83], p = 0.32).
conclusionLeft ventricular hypertrophy is not an independent risk factor for ventricular arrhythmia in MVP. Ventricular arrhythmogenesis in MVP is predominantly determined by mitral morphological factors and heart failure. Further work is required to better understand the predisposition to sudden death of patients with MVP and increased ventricular mass.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.